News
11d
Clinical Trials Arena on MSNAI should unlock clinical trial data, say expertsIndustry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...
Independent report confirms Ambience Healthcare’s AI platform reduces clinician burnout, enhances patient care, and ...
AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...
11h
Clinical Trials Arena on MSNDeveloping resilient strategies to overcome challenges in clinical research in EuropeEurope conference, which took place between 29 and 30 April in Barcelona, Spain, industry experts delivered comprehensive ...
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation ...
Sanofi, Recursion, and Velocity Clinical Research Executives Join Council as Founding Members to Guide Responsible AI Use in Clinical Research and Drive Tangible Improvements in Study Design and ...
The COVID-19 pandemic, however, offered a rare proof of concept. Health systems that coordinated HIT–BMI resources ...
Every Cure—the overall winner of Newsweek's inaugural AI Impact Awards—is finding hidden disease cures on dusty drugstore ...
AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...
Peter Ronco, CEO, Emmes, explains why AI in clinical development still needs human oversight despite widespread hype.
During a panel discussion on AI in clinical research, Prasanna Rao, Chief Products and Innovation officer at Saama emphasised the importance of making protocol data available to large language ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results